![]() |
Volumn 2, Issue 9, 2004, Pages 692-693
|
Leishmaniasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE;
INSECTICIDE;
MILTEFOSINE;
PARASITE ANTIGEN;
PAROMOMYCIN;
PHOSPHORYLCHOLINE;
PROTOZOAL VACCINE;
RECOMBINANT VACCINE;
AGGLUTINATION TEST;
ANTIGEN DETECTION;
BED NET;
CHROMATOGRAPHY;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC PROCEDURE;
DIFFERENTIAL DIAGNOSIS;
DISEASE SEVERITY;
DISEASE TRANSMISSION;
DRUG TARGETING;
EPIDEMIOLOGICAL DATA;
ERADICATION THERAPY;
FINANCIAL MANAGEMENT;
GENE SEQUENCE;
GENOME ANALYSIS;
GEOGRAPHIC DISTRIBUTION;
HEALTH PROGRAM;
HIGH RISK POPULATION;
HUMAN;
INCIDENCE;
INFECTION CONTROL;
INTERMETHOD COMPARISON;
LEISHMANIA;
LEISHMANIASIS;
MALARIA;
MEDICAL RESEARCH;
NONHUMAN;
NOTE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PSYCHODIDAE;
TERATOGENICITY;
VACCINATION;
WORLD HEALTH ORGANIZATION;
ANIMALS;
ANTIPROTOZOAL AGENTS;
HUMANS;
INSECT CONTROL;
LEISHMANIA;
LEISHMANIASIS;
PAROMOMYCIN;
PHOSPHORYLCHOLINE;
PROTOZOAN VACCINES;
PSYCHODIDAE;
|
EID: 4444382727
PISSN: 17401526
EISSN: None
Source Type: Journal
DOI: 10.1038/nrmicro981 Document Type: Note |
Times cited : (149)
|
References (16)
|